- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01354600
Effects of Positive Energy Balance and Exercise on Appetite Hormones in Sedentary Men and Women
Short-term Positive Energy Balance and Exercise on 24-hour Plasma Levels of Hunger and Satiety Hormones in Sedentary Lean and Obese Men and Women
The purpose of this research study is to examine the effects of overfeeding and exercise on blood levels of hormones associated with regulating appetite, also thought of as feelings of hunger and satiety (fullness). Previous studies have shown that non-obese people have different amounts of these hormones in their blood compared to obese people.
The investigators hypothesize that exercise will promote improved insulin sensitivity and corresponding beneficial changes in obese individuals. The investigators predict exercise induced changes in 24-hour plasma hormone levels will be associated with improved appetite during overfeeding in obese individuals.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In a randomized cross-over design, participants will complete two separate six-day & seven night inpatient stays (separated by at least 4 weeks) at the University of Wisconsin Hospital's Clinical and Translational Research Core (CTRC). During each six-day & seven night visit, participants will be fed an energy balance diet (energy intake = energy expenditure) for the first three days followed by three days of overfeeding (130% of the energy balance diet). During one of the inpatient periods, participants will exercise twice daily (once in the morning, once in the evening) for a total of approximately 120 minutes per day on an indoor exercise bicycle at ~50% of maximal aerobic fitness. During the other inpatient visit, participants will not exercise and will be inactive.
The investigators will examine the effect of short-term positive energy balance and exercise on 24-hour plasma levels of hormones related to hunger and satiety. These hormones include leptin, ghrelin, insulin, and peptide YY in sedentary lean and obese men and women. Our primary hypothesis is that when an obese person exercises, average 24-hour plasma leptin levels will increase in obese individuals during overfeeding compared to energy balance feeding, but fail to do so under sedentary conditions. In contrast, the investigators predict lean individuals will have an appropriate increase in average 24-hour leptin levels in response to overfeeding regardless of exercise treatment. Thus, the investigators suggest that a failure in the average 24-hour leptin response to overfeeding sets an obese person up for continued slow weight gain, as the leptin hunger signal fails to detect short-term overfeeding and does not produce a response. The investigators hypothesize that exercise will promote improved insulin sensitivity and increased leptin in the obese. The investigators predict that changes in average 24-hour plasma leptin levels will correlate with self-selected energy intake in lean individuals, but only during overfeeding plus exercise in obese individuals.
In addition, because the hunger and satiety response in humans is complex, this study will characterize the average 24-hour plasma levels of ghrelin, which stimulates hunger, and peptide YY, which stimulate satiety or fullness, in lean and obese individuals to determine if plasma levels are altered in obesity and in response to short-term positive energy balance.
Lastly, this study involves the banking of blood tissue specimens for future research. If it is decided such analysis is of scientific value, genetic analysis will be conducted for alterations in genes involved in the synthesis of, or receptors for, hunger and satiety hormones to be investigated under this study design.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53792
- University of Wisconsin Hospitals, Clinical and Translational Research Core (CTRC)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy body mass index (BMI) = 19 < 25 kg/m2
- Obese BMI = 30 < 35 kg/m2
- Activity level = sedentary: Total energy expenditure/resting metabolic rate < 1.6 (average US adult level)
Exclusion Criteria:
- Tobacco use
- Regular exercise or physical activity, defined as > 2h/week of moderate to vigorous activity;
- Individuals who do not eat breakfast
- Weight loss of > 3% of body weight over the previous six months
- Eating a special diet (e.g., vegetarian or low-carbohydrate)
- Current diagnosis of, or using prescription medications for, thyroid dysfunction, type I or type II diabetes, hypertension, cardiovascular, kidney, or liver disease;
- Taking other prescription medications or over-the-country products that alter energy metabolism (other than birth control pills)
- Allergies to any of the foods used in the study
- Individuals who donated blood within 8 weeks prior to enrollment or who plan to give blood during the course of the study
- Claustrophobia
- History of exercise intolerance, including diagnosed exercise induced asthma or any physical limitations to seated cycling aerobic exercise
- Blood chemistries in excess of 130% of the upper normal level and/or hemoglobin or hematocrit below the normal range.
- Females that are pregnant (pregnancy status to be tested at the beginning of each 6-day metabolic chamber stay), lactating, or have irregular menses
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
OTHER: Energy Balance
|
Daily cycling exercise at 50% maximal aerobic fitness for a total of ~120 minutes/day or no daily exercise (sedentary)
|
|
OTHER: Positive Energy Balance
|
Daily cycling exercise at 50% maximal aerobic fitness for a total of ~120 minutes/day or no daily exercise (sedentary)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood plasma appetite hormone concentrations
Time Frame: Two separate six day & seven night inpatient visits, separated by at least 4 weeks.
|
Blood samples will be drawn over 24 hours on the third and sixth day of each inpatient visit.
|
Two separate six day & seven night inpatient visits, separated by at least 4 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perceived subjective appetite measured by visual analog scales
Time Frame: Two separate six day & seven night inpatient visits, separated by at least 4 weeks.
|
Appetite questionnaires will be filled out hourly as well as every 30 minutes after meals from 8:00am to 11:00pm on the third and sixth day of each inpatient visit.
|
Two separate six day & seven night inpatient visits, separated by at least 4 weeks.
|
|
Energy intake at a breakfast buffet
Time Frame: Two separate six day inpatient visits, separated by at least 4 weeks.
|
A breakfast buffet will be served the morning after day 3 and day 6 of each inpatient visit to assess food intake following either energy balance (days 1-3) or overfeeding (days 4-6) with or without daily exercise.
|
Two separate six day inpatient visits, separated by at least 4 weeks.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Dale A Schoeller, PhD, University of Wisconsin-Madison, Dept. of Nutritional Sciences
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-2009-0001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Appetite and General Nutritional Disorders
-
University of Missouri-ColumbiaCompletedAppetite and General Nutritional DisordersUnited States
-
Purdue UniversitySuspendedAppetite and General Nutritional DisordersUnited States
-
University Hospital, Basel, SwitzerlandCompletedAppetite and General Nutritional DisordersSwitzerland
-
University Hospital, Basel, SwitzerlandCompletedAppetite and General Nutritional Disorders | Hormone ReplacementSwitzerland
-
University of WestminsterCoventry UniversityCompletedAppetite and General Nutritional DisordersUnited Kingdom
-
University College, LondonUnknownSedentary Lifestyle | Appetite and General Nutritional DisordersUnited Kingdom
-
University of WestminsterCompletedAdvanced Protein-based Program for Effective Treatment of Appetite Regulation and Obesity (APPETITE)Appetite and General Nutritional DisordersUnited Kingdom
-
Ospedale San DonatoUnknownObesity | Appetite and General Nutritional Disorders | Food CravingItaly
-
University of WashingtonColumbia University; Fred Hutchinson Cancer CenterCompleted
-
Harokopio UniversityNational and Kapodistrian University of AthensCompleted
Clinical Trials on Exercise or Sedentary
-
USDA Grand Forks Human Nutrition Research CenterCompletedObesity | Overweight | Physical ActivityUnited States
-
University of Colorado, DenverCompleted
-
University of Massachusetts, AmherstNational Heart, Lung, and Blood Institute (NHLBI)CompletedSedentary Time | Habitual Physical ActivityUnited States
-
Hasselt UniversityRecruitingExercise | Sedentary Behavior | Lipid Metabolism DisorderBelgium
-
Hacettepe UniversityHacettepe University Scientific Research Projects Coordination UnitNot yet recruitingSubstrate Oxidation | Postprandial Metabolism | Exercise Physiology | Cardiovascular Risk MarkersTurkey (Türkiye)
-
Heidelberg UniversityRecruitingPulmonary Hypertension | Chronic Thromboembolic Pulmonary HypertensionGermany
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Obesity | Insulin Resistance | Hyperlipidemia | Metabolic Syndrome XUnited States
-
Gümüşhane UniversıtyCompletedQuality of Life | Aerobic Exercise | Psychological Resilience | Zumba ExerciseTurkey (Türkiye)
-
Chulalongkorn UniversityCompletedSmoking Cessation | Smoker LungThailand
-
USDA Grand Forks Human Nutrition Research CenterCompleted